Next Article in Journal
KDM2 Family Members are Regulated by HIF-1 in Hypoxia
Next Article in Special Issue
Induced Pluripotent Stem Cell-Derived Red Blood Cells and Platelet Concentrates: From Bench to Bedside
Previous Article in Journal
Invariant Chain Complexes and Clusters as Platforms for MIF Signaling
Previous Article in Special Issue
May I Cut in? Gene Editing Approaches in Human Induced Pluripotent Stem Cells
Article Menu
Issue 1 (March) cover image

Export Article

Open AccessReview

Application of Induced Pluripotent Stem Cell Technology to the Study of Hematological Diseases

Department of Translational Medicine, University of Eastern Piedmont, Novara 28100, Italy
*
Author to whom correspondence should be addressed.
Academic Editor: Giovanni Amabile
Received: 27 January 2017 / Accepted: 3 March 2017 / Published: 8 March 2017
(This article belongs to the Special Issue Ten Years of iPSCs: Current Status and Future Perspectives)
Full-Text   |   PDF [1213 KB, uploaded 14 March 2017]   |  

Abstract

The burst of reprogramming technology in recent years has revolutionized the field of stem cell biology, offering new opportunities for personalized, regenerative therapies. The direct reprogramming of somatic cells to induced pluripotent stem cells (iPSCs) has provided an invaluable tool to study and model a wide range of human diseases. Here, we review the transforming potential of such a strategy in research and in therapies applicable to the hematology field. View Full-Text
Keywords: regenerative medicine; blood diseases; reprogramming; cancer regenerative medicine; blood diseases; reprogramming; cancer
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Li, M.; Cascino, P.; Ummarino, S.; Di Ruscio, A. Application of Induced Pluripotent Stem Cell Technology to the Study of Hematological Diseases. Cells 2017, 6, 7.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Cells EISSN 2073-4409 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top